lillydirect tirzepatide Zepbound price cut: Eli Lilly lowers cost of weight loss drug You Can Now Get Weight-Loss

Results showed that participants who received semaglutide experienced greater improvements in cardiometabolic risk factors and physical functioning than those who received a placebo

This decline happens naturally with age, but obesity accelerates the process significantly

Drugs that require rapid absorption or have narrow therapeutic windows may need timing adjustments

Since GLP - 1 drugs expanded their weight - loss indication, they have shown the potential to become the "drug of the year"

To assess changes in prescribing after the FDAs November 2025 removal of boxed warnings from several hormone therapies, we also compared prescribing rates between November 2025 and May 2026